Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Towards a scoring system depending on laboratory and ultrasound findingsfor the detection of hepatic fibrosis in chronic HCV infected patients

Non-invasive prediction of oesophageal varices with FibroScan and Doppler U/S in HCV patients with cirrhosis

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Role of transient elastography (fibroscan) in assessment of liver fibrosis in chronic hepatitis C patients